Earnings Alerts

Walgreens Boots Alliance (WBA) Earnings: 2Q Adjusted EPS Surpasses Estimates with $38.59 Billion in Sales

  • Walgreens Boots’ second-quarter adjusted earnings per share (EPS) were 63 cents, surpassing the estimated 52 cents.
  • Total sales for Walgreens Boots reached $38.59 billion, exceeding expectations of $38.03 billion.
  • US retail pharmacy sales amounted to $30.38 billion, higher than the projected $29.53 billion.
  • US healthcare sales came in at $2.15 billion, slightly below the anticipated $2.27 billion.
  • International sales were $6.1 billion, not meeting the forecast of $6.22 billion.
  • Analyst ratings for Walgreens Boots include 1 buy, 13 holds, and 1 sell.

Walgreens Boots Alliance on Smartkarma

Analysts on Smartkarma are providing diverse perspectives on Walgreens Boots Alliance. Behind the Money suggests a bearish lean, highlighting the stock’s struggles against e-commerce giants like Amazon. Sycamore Partners’ $24 billion buyout offer adds a new dimension to the healthcare market, attracting attention from private equity firms cautious of retail investments.

On the other hand, Baptista Research leans bullish, focusing on Walgreens Boots Alliance‘s strategic initiatives. They point out the company’s progress in optimizing store footprint and enhancing script retention rates after closures, indicating a positive response to challenges. The ongoing buzz about a potential buyout with Sycamore Partners has also lifted the company’s shares amidst a tough operational environment.


A look at Walgreens Boots Alliance Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth2
Resilience2
Momentum5
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Walgreens Boots Alliance has a positive long-term outlook. With high scores in Dividend and Momentum, it indicates that the company is strong in providing shareholder returns and has strong market momentum. Additionally, the Value score suggests that the company is trading at an attractive valuation. However, lower scores in Growth and Resilience indicate that there may be challenges in terms of growth opportunities and the company’s ability to withstand economic shocks.

Walgreens Boots Alliance, Inc. operates retail drugstores offering a wide range of prescription and non-prescription drugs, along with general merchandise. The company also provides various health services, including primary and acute care, pharmacy services, and health management. With a solid Dividend score and strong Momentum, investors may find Walgreens Boots Alliance an attractive option for steady income and potential market performance.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars